Our Projects

Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.

Our grant projects apply the best that science has to offer to the fight against HIV and co-infections, tuberculosis and malaria in lower-resource countries.

 

 

Filters / Search

Grant focus
To develop long-acting formulations of key medicines and create a market for them

Grantees
University of Liverpool

Status
Current

Amount
US$ 32,004,459

Disease
Hepatitis C, HIV and Co-Infection, Malaria, Tuberculosis

Long-acting medicines for malaria, tuberculosis and hepatitis C

View More

Grant focus
The IMPACT project seeks to interrupt malaria transmission

Grantees
MedinCell

Status
Current

Amount
US$ 6,358,125

Disease
Malaria

Long-acting medicines for innovative vector control

View More

Grant focus
To evaluate the mass-distribution of ivermectin to humans and livestock in two African countries during the malaria season.

Grantees
Barcelona Institute for Global Health (ISGlobal)

Status
Current

Amount
US$ 25,316,950

Disease
Malaria

Evaluating mass-distribution of anti-parasitic drugs to fight malaria

View More

Grant focus
To evaluate slow-release repellents that drive mosquitoes from inhabited areas

Grantees
University of Notre Dame

Status
Current

Amount
US$ 33,724,865

Disease
Malaria

Innovative repellents for disease-carrying mosquitoes

View More

Grant focus
Overcome barriers to availability, quality and supply of medicines for severe malaria and malaria prevention

Grantees
Medicines for Malaria Venture (MMV)

Status
Current

Amount
US$ 3,361,023

Disease
Malaria

Quality-assured medicines to prevent and treat malaria

View More

Grant focus
Collect data to determine whether a large-scale introduction of a malaria vaccine in Africa is workable.

Grantees
World Health Organization

Status
Current

Amount
US$ 9,600,000

Disease
Malaria

Piloting the world’s first malaria vaccine

View More

Grant focus
Provide pregnant women with intermittent doses of sulfadoxine-pyramethamine, a medicine that prevents malaria, and gather data on delivery through community health workers.

Grantees
Jhpiego

Status
Current

Amount
US$ 51,593,329

Disease
Malaria

Preventive malaria medicine to protect pregnant women and their babies

View More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.